STOCK TITAN

Synaptogenix unveils TAO purchase & BitGo custody in new crypto strategy

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Synaptogenix, Inc. (Nasdaq: SNPX) filed an 8-K on June 24, 2025 disclosing two related developments under Items 7.01 and 8.01.

First, the Company executed its initial purchase of the cryptocurrency “TAO” as the opening step in a previously announced digital-asset treasury strategy. Funding for the acquisition came directly from existing cash on the balance sheet; no external financing or equity issuance was mentioned.

Second, Synaptogenix appointed BitGo Trust Company, Inc. as its qualified custodian and trading partner. BitGo will (1) hold the Company’s TAO in regulated, insured cold storage, (2) facilitate additional TAO purchases via its platforms and OTC desk, and (3) enable TAO to be staked directly from custody. Management states that staking has already begun to generate revenue, positioning the digital-asset holdings as an income-producing treasury component while maintaining security and compliance.

No dollar amounts, number of tokens, staking yields, or risk-management parameters were provided in the filing. A press release containing the same information was furnished as Exhibit 99.1 and is expressly not incorporated by reference into Exchange Act filings.

Key investor takeaways:

  • Synaptogenix is now exposed to cryptocurrency price volatility and operational risks.
  • The partnership with a regulated custodian and the revenue-generating staking model signal an intent to treat TAO as a strategic, yield-bearing asset rather than a passive holding.
  • Absence of quantitative disclosures limits assessment of materiality at this stage.

Positive

  • Initiated revenue-generating TAO staking, creating a new income stream.
  • Engaged BitGo Trust Company for regulated, insured custody and trading, reducing operational and security risks.

Negative

  • No disclosure of investment size, cost basis, or expected yield, making materiality impossible to assess.
  • Introduces cryptocurrency price and regulatory risk to the balance sheet without stated risk-management framework.

Insights

TL;DR – Crypto treasury debut adds diversified revenue potential but with unquantified exposure.

Synaptogenix’s purchase of TAO and selection of BitGo marks a strategic shift toward digital-asset management. Custodial choice mitigates operational risk and immediate staking income offers a modest new revenue source, yet the filing omits size, cost basis, or yield, preventing a clear view of financial impact. Investors must weigh potential upside from staking yield against heightened balance-sheet volatility and regulatory uncertainties.

TL;DR – Staking via BitGo shows institutional-grade setup; lack of metrics clouds value.

Choosing BitGo Trust provides insured cold storage, qualified custody, and OTC liquidity—hallmarks of an institutional crypto-treasury program. Direct-from-custody staking streamlines yield generation while maintaining compliance. However, without token quantity, APY, or allocation limits, stakeholders cannot gauge risk concentration or earnings sensitivity to TAO’s price swings. The announcement is transformative in intent but indeterminate in scale.

Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
false 0001571934 0001571934 2025-06-24 2025-06-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 24, 2025

 

Synaptogenix, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-40458   46-1585656
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

1185 Avenue of the Americas, 3rd Floor
New York, New York 10036
(Address of principal executive offices and zip code)

 

Registrant’s telephone number, including area code: (973) 242-0005

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading
Symbol(s)
  Name of each exchange on which
registered
Common Stock, $0.0001 par value per share   SNPX   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company. x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 7.01. Regulation FD.

 

On June 24, 2025, Synaptogenix, Inc. (the “Company”) issued a press release announcing (i) its initial purchase of TAO as part of the Company's recently announced cryptocurrency treasury and (ii) that BitGo has been selected to provide qualified custody, staking and trading services for the Company’s TAO holdings. A copy of the press release is attached as Exhibit 99.1 hereto.

 

The information in this Item 7.01 to this Current Report on Form 8-K, and in Exhibit 99.1 furnished herewith, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

Item 8.01. Other Events.

 

On June 24, 2025, the Company announced its initial purchase of TAO as part of the Company's recently announced cryptocurrency treasury strategy and (ii) that BitGo has been selected to provide qualified custody, staking and trading services for the Company’s TAO holdings.

 

BitGo will secure the Company’s digital assets in regulated, insured cold storage with BitGo Trust Company, Inc. and facilitate the Company's planned acquisitions of TAO through its affiliated trading platforms, including access to liquidity via its OTC desk. TAO will be staked directly from qualified custody with BitGo Trust, enabling the Company to generate yield while maintaining security and regulatory compliance. The Company has begun to generate revenue through TAO staking. The initial acquisition of TAO was funded by the Company's cash reserves and balance sheet.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit Description
99.1 Press Release dated June 24, 2025
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  SYNAPTOGENIX, INC.

 

Date: June 24, 2025 By: /s/ Robert Weinstein
  Name: Robert Weinstein
  Title: Chief Financial Officer